OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $310 | -17.6% | 80,800 | -29.6% | 0.00% | 0.0% |
| Q2 2023 | $376 | +20.9% | 114,700 | -4.9% | 0.00% | – |
| Q1 2023 | $311 | +39.5% | 120,600 | +0.7% | 0.00% | – |
| Q4 2022 | $223 | -99.9% | 119,800 | +0.8% | 0.00% | – |
| Q3 2022 | $219,000 | -17.7% | 118,800 | -4.0% | 0.00% | – |
| Q2 2022 | $266,000 | 0.0% | 123,800 | +46.0% | 0.00% | – |
| Q1 2022 | $266,000 | +41.5% | 84,800 | +44.7% | 0.00% | – |
| Q4 2021 | $188,000 | +62.1% | 58,600 | +69.9% | 0.00% | – |
| Q3 2021 | $116,000 | -92.9% | 34,500 | -95.1% | 0.00% | -100.0% |
| Q4 2020 | $1,641,000 | -64.3% | 710,507 | +13.8% | 0.00% | -50.0% |
| Q2 2020 | $4,600,000 | +81.0% | 624,109 | -26.8% | 0.00% | +100.0% |
| Q1 2020 | $2,541,000 | -43.6% | 852,843 | -21.4% | 0.00% | -33.3% |
| Q4 2019 | $4,502,000 | +136.8% | 1,084,709 | +84.9% | 0.00% | +50.0% |
| Q3 2019 | $1,901,000 | +118.0% | 586,725 | +24.4% | 0.00% | +100.0% |
| Q2 2019 | $872,000 | +35.6% | 471,609 | +29.8% | 0.00% | 0.0% |
| Q1 2019 | $643,000 | +383.5% | 363,217 | +559.2% | 0.00% | – |
| Q4 2018 | $133,000 | – | 55,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TLS Advisors LLC | 1,319,679 | $4,329 | 18.57% |
| Madison Avenue Partners, LP | 3,307,605 | $10,848,943 | 2.37% |
| CHI Advisors LLC | 864,822 | $2,836,616 | 0.86% |
| Rubric Capital Management LP | 5,445,910 | $17,862,585 | 0.76% |
| BVF INC/IL | 6,851,051 | $22,471,447 | 0.63% |
| EcoR1 Capital, LLC | 6,117,400 | $20,065,072 | 0.49% |
| Artal Group S.A. | 2,500,000 | $8,200 | 0.25% |
| Tejara Capital Ltd | 112,591 | $369,298 | 0.18% |
| DCF Advisers, LLC | 64,764 | $212,426 | 0.11% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 801,152 | $2,627,779 | 0.06% |